SciELO - Scientific Electronic Library Online

 
vol.22 número4Therapeutic alternatives to pharmacological management with statin drugs in adults with dyslipidemia. Systematic literature review and general recommendationsCardiac tamponade as an explanation for thrombolytic therapy in patient with massive pulmonary embolism índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Revista Colombiana de Cardiología

versão impressa ISSN 0120-5633

Resumo

MANZUR, Fernando; ANGEL, Keyla  e  CORRALES, Hugo. Cardiovascular manifestations of sickle cell disease. Rev. Colomb. Cardiol. [online]. 2015, vol.22, n.4, pp.187-196. ISSN 0120-5633.  https://doi.org/10.1016/j.rccar.2015.03.011.

Sickle cell anemia is an inherited hemoglobinopathy caused by the presence of hemoglobin S, which lowers the solubility and through the process of polymerization results in sickle erythrocytes obstructing the microvascular network. This entity is characterized by episodes of ischemia-reperfusion injury to vital organs, contributing to its dysfunction. The advent of inducing fetal hemoglobin therapy associated with antibiotic prophylaxis has allowed prolonged survival. However, by increasing longevity, cardiovascular complications are evident, with the development of systemic vascular disease, acute myocardial infarction, pulmonary arterial hypertension and left ventricular dysfunction. The aim of this paper is to review the pathophysiology and treatment of major cardiovascular events in patients with sickle cell anemia.

Palavras-chave : Cardiovascular disease; Anemia; Myocardial infarction; Pulmonary arterial hypertension.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )